Spectral AI, Inc. (NASDAQ: MDAI) is one of the most popular AI penny stocks to buy according to billionaires. On June 30, ...

Marcel Botha discusses ways the agency can ensure it gets the most accurate results possible from AI.

The burden then shifts to hospitals, which puts clinicians in a tough spot, relying on AI that might not generalize, with no ...

The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...

The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside experts.

Joseph Jeanmarie dealt with the pain, mostly working at a pain level of eight out of 10. Now, new technology his helping him ...

One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

Kennedy Jr. appeared on the latest episode of Tucker Carlson’s podcast on Monday and it’s filled with the ramblings of a man ...

New foundational AI models are accelerating advancements in biomedical research, according to a speaker at Cleveland Clinic’s ...

Importantly, no serious safety concerns were reported in PATHFINDER 2. Detailed PATHFINDER 2 data are expected to be ...